Management of Sleep Disturbances in Elderly Patients with Heart Failure and Atrial Fibrillation

Introduction to Sleep Management

The American Academy of Sleep Medicine recommends cognitive behavioral therapy for insomnia (CBT-I) and sleep hygiene education as the initial approach for older adults with sleep disturbances, due to their efficacy without medication risks 1, 2
The American Geriatrics Society suggests maintaining stable bedtimes and rising times, avoiding daytime napping after 2 PM, and avoiding sleep-fragmenting substances like caffeine and alcohol 2
The American Academy of Sleep Medicine advises using the bedroom only for sleep and sex; if unable to fall asleep within 20 minutes, leaving the bedroom and returning only when sleepy 2

The American Academy of Sleep Medicine recommends FDA-approved hypnotics specifically studied in elderly populations, such as zaleplon 5mg, zolpidem 6.25mg controlled-release, and eszopiclone, over diphenhydramine due to lower frequency and severity of adverse effects 1, 2
The American College of Cardiology suggests that benzodiazepine receptor agonists have lower adverse effects compared to older agents, with dosing reduced by 50% in elderly patients 8
The European Heart Journal notes that ramelteon 8mg, a melatonin receptor agonist, is appropriate for sleep-onset insomnia with no short-term usage restrictions and minimal adverse effects 1, 5

The American College of Cardiology recommends ensuring adequate rate control is achieved before addressing insomnia in patients with heart failure and atrial fibrillation, as tachycardia itself disrupts sleep 6, 8
The European Heart Journal suggests that beta-blockers used for rate control in atrial fibrillation may provide dual benefit by improving sleep architecture through heart rate reduction 8, 9

The American Academy of Sleep Medicine advises assessing for sleep apnea, which is common in heart failure patients and contraindicated with sedative-hypnotics due to respiratory depression risk 1
The American Geriatrics Society recommends reviewing all current medications for potential drug interactions and cumulative sedative effects 1, 2
The European Heart Journal notes that evaluating renal function is crucial, as elderly heart failure patients frequently have compromised clearance affecting drug dosing 10

The American Academy of Sleep Medicine suggests that melatonin 2mg prolonged-release taken 1-2 hours before bedtime is the safest over-the-counter alternative, though evidence for efficacy is weak 5
The European Heart Journal notes that melatonin has no significant drug interactions with cardiac medications and is not listed on Beers Criteria, representing lower risk than diphenhydramine 5